Cargando…

Tocilizumab for refractory morphea in adults: A case series

Detalles Bibliográficos
Autores principales:	Lonowski, Sarah, Goldman, Nathaniel, Kassamali, Bina, Shahriari, Neda, LaChance, Avery, Vleugels, Ruth Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637845/ https://www.ncbi.nlm.nih.gov/pubmed/36353292 http://dx.doi.org/10.1016/j.jdcr.2022.09.024

Ejemplares similares

A case of paradoxical fibrosis and development of morphea in a patient on dupilumab
por: Kassamali, Bina, et al.
Publicado: (2021)

Distinctive cutaneous features of dermatomyositis in Black adults: A case series
por: Ezeofor, Adaeze J., et al.
Publicado: (2023)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
por: Shahriari, Neda, et al.
Publicado: (2023)

Apremilast as a treatment for morphea: A case series
por: Koschitzky, Merav, et al.
Publicado: (2021)

Exploring Dermatomyositis through an Interdisciplinary Lens: Pearls from Dermatology and Rheumatology
por: Kassamali, Bina, et al.
Publicado: (2021)

Differences in virtual care utilization for acne by vulnerable populations during the COVID-19 pandemic: A retrospective review
por: Lee, Michelle S., et al.
Publicado: (2021)

Characteristics and treatment of silicone granulomas: A retrospective multicenter cohort of 21 patients
por: Kassamali, Bina, et al.
Publicado: (2021)

Telemedicine and the battle for health equity: Translating temporary regulatory orders into sustained policy change
por: Kassamali, Bina, et al.
Publicado: (2020)

Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet’s syndrome: case series and literature review
por: Liu, Jinjing, et al.
Publicado: (2020)

The Correction of Facial Morphea Lesions by Hyaluronic Acid: A Case Series and Literature Review
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Diagnosis and Management of Cutaneous Manifestations of Autoimmune Connective Tissue Diseases
por: Goldman, Nathaniel, et al.
Publicado: (2022)

Understanding the impact of teledermatology on no-show rates and health care accessibility: A retrospective chart review
por: Franciosi, Ellen B., et al.
Publicado: (2021)

Importance of nose wires in face masks: A reply to “Diagnostic and management considerations for “maskne” in the era of COVID-19”
por: Kassamali, Bina, et al.
Publicado: (2021)

Morphea-like lesions after botulinum toxin A injections
por: Landau, Marina, et al.
Publicado: (2020)

Superficial morphea: A rare condition and report of three unique cases
por: Bommareddy, Kanthi, et al.
Publicado: (2021)

Pilot use of 3-dimensional photography to aid clinical decision-making in craniofacial morphea
por: Ganske, Ingrid M., et al.
Publicado: (2022)

Radiation‐induced morphea of the breast—A case series
por: Finnegan, Paula, et al.
Publicado: (2022)

Methotrexate: an effective monotherapy for refractory generalized morphea
por: Platsidaki, Eftychia, et al.
Publicado: (2017)

Increasing evidence for omalizumab in the treatment of bullous pemphigoid
por: Lonowski, Sarah, et al.
Publicado: (2020)

Role of Tocilizumab in the Treatment of COVID-19 Patients with Cytokine Storm: A Case Series
por: Basnet, Ajaya, et al.
Publicado: (2022)

Hidradenitis suppurativa in acute myeloid leukemia: Review of disease course and management
por: Chen, Stella X., et al.
Publicado: (2021)

Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series
por: Cui, Ran, et al.
Publicado: (2021)

Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series
por: Mady, Ahmed, et al.
Publicado: (2020)

Omalizumab in Severe Refractory Vernal Keratoconjunctivitis in Children: Case Series and Review of the Literature
por: Doan, Serge, et al.
Publicado: (2016)

Tocilizumab and liver injury in patients with COVID-19
por: Serviddio, Gaetano, et al.
Publicado: (2020)

Patient crowdfunding for inflammatory skin disease
por: Goldman, Nathaniel, et al.
Publicado: (2022)

Outcome of patients with sarcoidosis refractory to TNF antagonists: a case series
por: Thery-Casari, Clémence, et al.
Publicado: (2018)

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
por: Mahamid, Mahmud, et al.
Publicado: (2011)

Dermoscopy of Morphea
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2019)

Repository corticotropin injection in patients with refractory psoriatic arthritis: a case series
por: Brown, Alan N
Publicado: (2016)

Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series
por: Zhang, Honghong, et al.
Publicado: (2017)

A case series: alternative access for refractory shock during cardiac arrest
por: Cui, Charles Q, et al.
Publicado: (2019)

Nonablative radiofrequency in the treatment of refractory vulvar lichen sclerosus: A case series
por: Balbinotti, Rodrigo Rossi, et al.
Publicado: (2021)

Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series
por: Levine, Todd
Publicado: (2012)

Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series
por: Lester, Jacobo, et al.
Publicado: (2018)

Orthogonal electrical cardioversion in atrial fibrillation refractory to biphasic shocks: a case series
por: Velázquez-Rodríguez, Enrique, et al.
Publicado: (2020)

Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series
por: Xu, Qingqing, et al.
Publicado: (2023)

Disease flare in patients with dermatomyositis following COVID-19 vaccination
por: Pan, Catherina X., et al.
Publicado: (2022)

Multisystem inflammatory syndrome-related refractory cardiogenic shock in adults after coronavirus disease 2019 infection: a case series
por: Tonon, David, et al.
Publicado: (2022)

Morphea on the breast and pregnancy
por: Benchat, Loubna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pnt9iohp1hapb5fif5mr22vg6r